1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Diabetes Therapy and Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Therapy and Drug Delivery Market Perspective (2017-2028)
2.2 Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Diabetes Therapy and Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diabetes Therapy and Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Diabetes Therapy and Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Therapy and Drug Delivery Revenue
3.4 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapy and Drug Delivery Revenue in 2021
3.5 Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Diabetes Therapy and Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diabetes Therapy and Drug Delivery Market Size (2017-2028)
6.2 North America Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Diabetes Therapy and Drug Delivery Market Size (2017-2028)
7.2 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Diabetes Therapy and Drug Delivery Market Size (2017-2028)
9.2 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Introduction
11.1.4 Abbott Laboratories Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.1.5 Abbott Laboratories Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Diabetes Therapy and Drug Delivery Introduction
11.2.4 Medtronic Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.2.5 Medtronic Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Diabetes Therapy and Drug Delivery Introduction
11.3.4 Sanofi Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.3.5 Sanofi Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Introduction
11.4.4 Novo Nordisk Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.4.5 Novo Nordisk Recent Development
11.5 MannKind
11.5.1 MannKind Company Detail
11.5.2 MannKind Business Overview
11.5.3 MannKind Diabetes Therapy and Drug Delivery Introduction
11.5.4 MannKind Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.5.5 MannKind Recent Development
11.6 Enteris BioPharma
11.6.1 Enteris BioPharma Company Detail
11.6.2 Enteris BioPharma Business Overview
11.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Introduction
11.6.4 Enteris BioPharma Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.6.5 Enteris BioPharma Recent Development
11.7 Dexcom
11.7.1 Dexcom Company Detail
11.7.2 Dexcom Business Overview
11.7.3 Dexcom Diabetes Therapy and Drug Delivery Introduction
11.7.4 Dexcom Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.7.5 Dexcom Recent Development
11.8 Senseonics Holding
11.8.1 Senseonics Holding Company Detail
11.8.2 Senseonics Holding Business Overview
11.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Introduction
11.8.4 Senseonics Holding Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.8.5 Senseonics Holding Recent Development
11.9 Medtech
11.9.1 Medtech Company Detail
11.9.2 Medtech Business Overview
11.9.3 Medtech Diabetes Therapy and Drug Delivery Introduction
11.9.4 Medtech Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.9.5 Medtech Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Introduction
11.10.4 Johnson & Johnson Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.10.5 Johnson & Johnson Recent Development
11.11 Synertech
11.11.1 Synertech Company Detail
11.11.2 Synertech Business Overview
11.11.3 Synertech Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Detail
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Detail
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Detail
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.14.5 Eli Lilly Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Detail
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Diabetes Therapy and Drug Delivery Business (2017-2022)
11.15.5 Transdermal Specialties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
